Navigating coronary heart disease

Written in association with: Dr Dwayne Conway
Published:
Edited by: Kate Forristal

Following on from his previous article on coronary heart disease, Dr Dwayne Conway gives us his insights into diagnostic tests to detect coronary heart disease and treatment options.

 

What diagnostic tests are used to detect coronary heart disease?

The most effective test for detecting coronary heart disease is a CT scan, which provides high-resolution images of the coronary arteries to identify atherosclerotic plaque and assess narrowing. To achieve optimal results, a gated CT is used, which synchronises image capture with the cardiac cycle and often requires heart rate-reducing medications. Not all CT units can perform cardiac CT, as it requires specialised equipment and monitoring, but it is becoming increasingly available in most areas of the UK.

 

Although a CT scan is excellent for identifying the presence of coronary artery disease, it may not reveal whether the disease affects blood flow. To assess its impact, several tests are available:

 

Electrocardiogram (ECG): This simple test measures the heart's electrical activity through leads on the chest and can detect circulation problems during chest pain.

 

Exercise ECG: This test involves treadmill walking while monitoring heart rate, blood pressure, and ECG to identify heart blood flow issues under physical stress.

 

Stress echo: Similar to an exercise ECG but with the addition of ultrasound to observe how the heart functions during exercise.

 

Nuclear perfusion scan: A radioactive substance is introduced into the bloodstream and taken up by the heart muscle. It helps compare blood flow at rest and during increased blood flow to assess abnormalities.

 

These tests focus on ischaemia, the decreased blood flow to the heart caused by coronary heart disease. They provide information about the impact of the coronary atherosclerosis on blood flow and heart function.

 

Invasive coronary angiography is another option, involving x-ray images with a contrast agent directly introduced into the coronary arteries via specially designed arterial catheters that need to be placed by expert cardiologists. It offers high-resolution images of arterial narrowings, blockages and the blood flow within the arteries. While CT excels at detecting plaque, invasive coronary angiography is better at assessing the severity of artery narrowing and artery flow.

 

 

What are the treatment options for coronary heart disease?

The treatment options for coronary heart disease are determined by the individual's condition. Atherosclerosis, the underlying disease, is managed primarily with statins, such as atorvastatin and rosuvastatin, which reduce harmful LDL cholesterol, slow down atherosclerosis progression, and have strong evidence for preventing heart attacks and strokes.

 

Other medications reduce the symptoms of angina, with options like beta blockers, amlodipine, and nitrates. Beta blockers lower the heart rate during exercise (reducing cardiac oxygen demand), while amlodipine and nitrates dilate blood vessels slightly (improving blood flow and also reducing cardiac oxygen demand).

 

During a heart attack, prompt medical attention is crucial, as there are additional medications which can reduce blood clots in the heart arteries, as well as procedures like angioplasty and stent placement aim to restore blood flow by physically unblocking the artery. Physical intervention, such as stents or bypass surgery, may also be considered for patients with stable angina if symptoms persist despite medications.

 

Aspirin is a notable therapy, as it inhibits platelets' clot-forming capability, reducing likelihood of sudden artery blockage. It is a simple and potentially life-saving treatment for a heart attack, where a blood clot is the usual culprit, and is recommended lifelong after a heart attack or stroke to reduce risk of recurrence. Aspirin is also recommended long-term after coronary angioplasty/stent procedures or heart bypass surgery, usually in combination with an additional anti-platelet drug, such as clopidogrel, prasugrel or ticagrelor for a few months.

 

Treatment for coronary heart disease is highly individualised, with statins being a cornerstone for managing the causative disease: atherosclerosis. Other medications are chosen based on symptoms and the stability of the condition, and physical interventions (coronary angioplasty, stents or bypass surgery) may also be offered according to the clinical situation.

 

Dr Dwayne Conway is a distinguished consultant interventional and general cardiologist with over 25 years of experience. You can schedule an appointment with Dr Conway on his Top Doctors profile.

By Dr Dwayne Conway
Cardiology

Dr Dwayne Sean Gavin Conway is a leading consultant interventional and general cardiologist based in Leeds and Sheffield who specialises in anginacoronary artery disease and coronary angioplasty, alongside atrial fibrillationheart failure and chest pain. His private practice is based at Nuffield Health Leeds Hospital and his NHS base is Sheffield Teaching Hospitals NHS Foundation Trust.

Dr Conway is highly qualified. He has an MB ChB and MD from the University of Birmingham and is a fellow of the Royal College of Physicians. He completed his postgraduate training in Birmingham, Warwick, York, Plymouth, London, Leeds and a 12-month Interventional Cardiology Fellowship at Dalhousie University, Canada. He holds a Certificate of Completion of Training in Cardiology (2006) and is on the Specialist Register of the General Medical Council.

Dr Conway established the coronary intervention service at Pinderfields Hospital, Wakefield, and is nationally respected for his educational work. He has directed regional and national courses for trainee cardiologists, including for the British Cardiovascular Intervention Society (BCIS). He is also the Deputy Training Programme Director for Cardiology in South Yorkshire.

Dr Conway has an international research profile. His MD thesis 'The prothrombotic state in atrial fibrillation: Potential mechanisms and clinical significance', was awarded with honours, and he has published in high-impact journals including The New England Journal of Medicine, Circulation, Heart, European Heart Journal, Journal of the American College of Cardiology, American Journal of Cardiology, American Heart Journal and the British Medical Journal. 

Dr Conway is a member of several professional organisations including the Royal College of Physicians, the British Cardiovascular Society and the British Cardiovascular Intervention Society. He is also a member of the European Association of Percutaneous Coronary Intervention, the British Medical Association and the Medical Defence Union.   

View Profile

Overall assessment of their patients


  • Related procedures
  • Heart attack
    Arrhythmia
    Hypertension (high blood pressure)
    Pericarditis
    Heart failure
    Injury valves
    Heart murmur
    Echocardiogram
    Electrocardiogram
    Ambulatory electrocardiogram (Holter)
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.